MicroRNAs and Human Disease - Olson, Chair
MicroRNA 与人类疾病 - Olson,主席
基本信息
- 批准号:8061929
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-14 至 2011-07-15
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAlberta provinceBiologyBlood VesselsCanadaCardiovascular DiseasesCentral Nervous System DiseasesChemistryClinicalCollaborationsCommunicable DiseasesDevelopmentDiagnosticDisciplineDiseaseEducational workshopFunctional RNAGene ExpressionGenesGoalsHeart DiseasesHuman BiologyIndustryJointsLearningMalignant NeoplasmsMethodsMicroRNAsMyopathyOligonucleotidesOutcomeRNARegulationReportingRequest for ProposalsResearchResearch PersonnelResearch SubjectsRoleScientistStem cellsStudentsTherapeuticTimeVirus DiseasesWorkbaseexperiencehuman diseasein vivoinsightinterestmeetingsnervous system disordernovelsymposiumtherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): This proposal requests support for a Keystone Symposia meeting entitled Microns and Human Disease, organized by Eric N. Olson, Safari Kauppinen and Eva van Rooij, which will be held in Banff, Alberta, Canada from February 11 - 16, 2011. MicroRNAs have emerged as key regulators of numerous diseases including cancer, heart disease, neurological disorders and vascular abnormalities. The Keystone Symposia meeting on MicroRNAs and Human Disease will focus on new discoveries surrounding the function and therapeutic opportunities of miRNAs in human disease. This meeting will bring together a broad range of scientific and clinical experts in a number of diseases. Because the meeting will be held concurrently with the Keystone Symposia meeting on MicroRNAs and Non-Coding RNAs and Cancer, this meeting will focus on diseases other than cancer, such as cardiovascular, muscle, infectious, and neurological diseases. Joint plenary sessions will focus on microRNA mechanisms of action and the identification of microRNA targets, as well as the latest advances on the roles of microRNAs in stem cells. The meetings will conclude with a combined session on recent advances in microRNA therapeutics.
PUBLIC HEALTH RELEVANCE: In the last few years it has become increasingly clear that microRNAs (miRNAs) - small segments of RNA that each regulate hundreds of genes - fulfill important roles in a variety of disease states like cancer, central nervous system disorders, viral, muscle and cardiovascular disease. Due to the apparent roles of miRNAs in multiple disease states, there has been a tremendous increase in interest in miRNA function and the feasibility of using these disease regulators as therapeutic targets and diagnostic tools. Based on rapid developments in this field, this Keystone Symposia meeting on MicroRNAs and Human Disease will provide insight and clarity regarding recent discoveries as well as facilitate interactions among scientific leaders, students and trainees working in this field.
描述(由申请人提供):该提案请求支持Keystone研讨会会议,标题为“ Microns and Human Deasany”,由Eric N. Olson,Safari Kauppinen和Eva Van Rooij组织,该组织将于2011年2月11日至16日在加拿大艾伯塔省艾伯塔省举行。异常。 Keystone研讨会会议上有关microRNA和人类疾病的会议将集中于有关人类疾病中miRNA功能和治疗机会的新发现。这次会议将汇集多种疾病的大量科学和临床专家。由于会议将同时举行有关MicroRNA和非编码RNA和癌症的Keystone研讨会会议,因此这次会议将集中于癌症以外的其他疾病,例如心血管,肌肉,肌肉,传染病和神经系统疾病。联合全体会议将集中于microRNA作用机理和鉴定microRNA靶标,以及关于microRNA在干细胞中作用的最新进展。会议将在MicroRNA治疗剂的最新进展中结束。
公共卫生相关性:在过去的几年中,越来越明显的是,microRNA(miRNA) - 每个调节数百个基因的RNA的一小部分 - 在癌症,中枢神经系统疾病,病毒,肌肉和心血管疾病等多种疾病状态中扮演重要角色。由于miRNA在多种疾病状态中的明显作用,因此对miRNA功能的兴趣有很大增加,以及使用这些疾病调节剂作为治疗靶标和诊断工具的可行性。基于该领域的快速发展,这次有关MicroRNA和人类疾病的Keystone研讨会会议将为最新发现以及促进在该领域工作的科学领袖,学生和学员之间的互动提供见解和清晰度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW D ROBERTSON其他文献
ANDREW D ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW D ROBERTSON', 18)}}的其他基金
Mechanisms of Cardiac Growth, Death and Regeneration
心脏生长、死亡和再生的机制
- 批准号:
8056942 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Environmental Epigenomics and Disease Susceptibility
环境表观基因组学和疾病易感性
- 批准号:
8130161 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Mycobacteria: Physiology, Metabolism and Pathogenesis - Back to the Basics
分枝杆菌:生理学、代谢和发病机制 - 回到基础
- 批准号:
8055811 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Immunity in the Respiratory Tract: Challenges of the Lung Environment
呼吸道免疫:肺部环境的挑战
- 批准号:
8057229 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Pathogenesis of Influenza: Virus-Host Interactions
流感的发病机制:病毒与宿主的相互作用
- 批准号:
8128073 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
昆虫药物:明天的抗炎药物
- 批准号:
8124051 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies
结核病:免疫学、细胞生物学和新型疫苗接种策略
- 批准号:
8055809 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses
NK 和 NKT 细胞生物学:先天反应的特异性和冗余
- 批准号:
8006107 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别:
相似海外基金
Novel Approaches Against Emerging Antimicrobial Resistance
对抗新出现的抗菌素耐药性的新方法
- 批准号:
10391767 - 财政年份:2022
- 资助金额:
$ 2万 - 项目类别:
B Cell Renaissance: Epigenetics, Regulation and Immunotherapy
B 细胞复兴:表观遗传学、调控和免疫疗法
- 批准号:
9910328 - 财政年份:2020
- 资助金额:
$ 2万 - 项目类别:
G Protein-Coupled Receptors: Molecular Mechanisms and Novel Functional Insights
G 蛋白偶联受体:分子机制和新的功能见解
- 批准号:
8199546 - 财政年份:2011
- 资助金额:
$ 2万 - 项目类别: